Kindeva Drug Delivery LP, based in Saint Paul, MN, stands as a leading global Contract Development and Manufacturing Organization (CDMO), specializing in drug delivery solutions. With a strong focus on aseptic fill-finish manufacturing, analytical services, and regulatory quality, Kindeva offers partners innovative and comprehensive solutions throughout the development and commercialization process.
Through their state-of-the-art facility in Bridgeton, MO, Kindeva boasts a notable capacity for aseptic injectables, ensuring Annex 1 compliance and streamlined production with cutting-edge automation. The company's commitment to combining sterile fill, device manufacturing, and final assembly under one roof accelerates timelines and simplifies the supply chain for their partners.
Kindeva's expertise extends to various delivery routes, including pulmonary, nasal, injectables, dermal, microneedle array patches, and transdermal products. With a legacy of innovation dating back to 1956, Kindeva continues to redefine industry standards, delivering high-quality drug-device combination products backed by decades of experience and a global footprint.
Generated from the website content
